PyInvesting

Market research

0101.KLSE Tmc Life Sciences Bhd

KLSE MYR Healthcare

Latest close

0.415 —

As of Nov 20, 2026

Test a moving-average rule with historical data.

Market facts

Market cap
732M
P/E ratio
42.0
Analyst target
Not available
Dividend yield
1.4%
Beta
0.31

Community

Investor discussion

1 comment

Admin profile picture
Admin

Apr 1, 2021

Tmc Life Sciences Bhd is currently in a long term downtrend where the price is trading 2.5% below its 200 day moving average.

From a valuation standpoint, the stock is 3.5% cheaper than other stocks from the Other sector with a price to sales ratio of 6.2.

Tmc Life Sciences Bhd's total revenue sank by 7.1% to $49M since the same quarter in the previous year.

Its net income has dropped by 32.1% to $5M since the same quarter in the previous year.

Finally, its free cash flow grew by 0.9% to $-26M since the same quarter in the previous year.

Based on the above factors, Tmc Life Sciences Bhd gets an overall score of 2/5.